CDKN2A Peptide | 45-033P

CDKN2A Peptide | 45-033P | Gentaur UK, US & Europe Distribution

Short Description: (CT) CDKN2A (isoform 1) / p16INK4a Peptide

Species: Human

Location: CDKN2A peptide corresponds to 15 amino acids near the C-terminus region of CDKN2A.

Tested Application: Bl

Application: CDKN2A Peptide is used for blocking the activity of CDKN2A antibody (catalog number 45-033). The CDKN2A antibody ships at 0.5 mg/mL and the CDKN2A Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.

Physical State: Lyophilized

Buffer: CDKN2A peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.

Concentration: N/A

Storage: Store at -20˚C. When reconstituted minimize freezing and thawing.

NCBI Official Symbol: CDKN2A

Alternate Names: ARF, MLM, P14, P16, P19, CMM2, INK4, MTS1, TP16, CDK4I, CDKN2, INK4A, MTS-1, P14ARF, P19ARF, P16INK4, P16INK4A, P16-INK4A, Cyclin-dependent kinase 4 inhibitor A

NCBI Gene ID: 1029

User Note: N/A

NCBI Official Name: Cyclin-Dependent Kinase Inhibitor 2A

Background: N/A

Disclaimer: This product is for research use only.